mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.09 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.09 |
mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.09 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.09 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.09 |
mRNA |
SZ4TA2 |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.1 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.1 |
mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.1 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |